Open AccessRoxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
Author(s) -
Wei-Hong Yu,
Xiejia Li,
Fang Yuan
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i23.6048
Subject(s) - medicine , erythropoietin , hemodialysis , anemia , epoetin alfa , intensive care medicine
Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) is a prevalent problem in patients with chronic kidney disease. It is associated with increased morbidity and mortality in patients who undergo dialysis. A significant proportion of patients do not respond to iron supplementation and conventional ESAs. We report a case of severe ESA hyporesponsiveness-related anemia that was successfully treated with oral roxadustat.